Method of enhancing activity of antibody composition of binding to Fcgamma receptor IIIa

Details for Australian Patent Application No. 2003236018 (hide)

Owner KYOWA HAKKO KOGYO CO., LTD.

Inventors Shitara, Kenya; Nakamura, Kazuyasu

Agent Spruson & Ferguson

Pub. Number AU-A-2003236018

PCT Number PCT/JP03/04504

PCT Pub. Number WO2003/085119

Priority 2002-106950 09.04.02 JP

Filing date 9 April 2003

Wipo publication date 20 October 2003

International Classifications

C12P 021/08 Preparation of peptides or proteins - Monoclonal antibodies

C07K 016/46 Immunoglobulins, e.g. monoclonal or polyclonal antibodies - Hybrid immunoglobulins

A61K 039/395 Medicinal preparations containing antigens or antibodies - Antibodies

A61P 009/00 Drugs for disorders of the cardiovascular system

A61P 029/00 Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 031/04 Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 031/12 Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 031/14 Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 035/00 Antineoplastic agents

A61P 037/02 Drugs for immunological or allergic disorders

A61P 037/04 Drugs for immunological or allergic disorders

A61P 037/08 Drugs for immunological or allergic disorders

A61P 043/00 Drugs for specific purposes, not provided for in groups

G01N 033/15 Investigating or analysing materials by specific methods not covered by groups - Medicinal preparations

C12N 015/09 Mutation or genetic engineering - Recombinant DNA-technology

C12N 005/10 Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C07K 016/18 Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from animals or humans

G01N 033/50 Investigating or analysing materials by specific methods not covered by groups - Chemical analysis of biological material, e.g. blood, urine

Event Publications

4 September 2003 Complete Application Filed

  Priority application(s): 2002-106950 09.04.02 JP

27 November 2003 Application Open to Public Inspection

  Published as AU-A-2003236018

9 April 2009 Alteration of Name

  The name of the applicant has been altered to Kyowa Hakko Kirin Co., Ltd.

4 November 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003236019-Drug containing antibody composition appropriate for patient suffering from Fc Gamma RIIIa polymorphism

2003236017-Drug containing antibody composition